A detailed history of Massmutual Trust CO Fsb transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 65 shares of EYPT stock, worth $542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 107 39.25%
Holding current value
$542
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$7.58 - $10.54 $318 - $442
-42 Reduced 39.25%
65 $0
Q2 2024

Jul 02, 2024

BUY
$8.16 - $22.89 $342 - $961
42 Added 64.62%
107 $0
Q1 2024

Apr 09, 2024

SELL
$19.93 - $29.71 $856 - $1,277
-43 Reduced 39.81%
65 $1,000
Q4 2022

Jan 06, 2023

BUY
$2.37 - $7.2 $28 - $86
12 Added 12.5%
108 $0
Q3 2022

Oct 07, 2022

BUY
$6.96 - $11.12 $292 - $467
42 Added 77.78%
96 $1,000
Q2 2022

Jul 07, 2022

BUY
$7.25 - $12.71 $391 - $686
54 New
54 $0

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $285M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.